Hensoldt's €10.4 Billion Order Book Sets the Bar Its Execution Must Now Clear
Published on 11/10/2026 at 03:20 | Editorial boerse-global.de
Hensoldt shares drew fresh attention on two fronts this week: a regulatory filing that revealed BlackRock's stake and a trading session that saw defence names lead a broader market recovery. The stock gained 6.4% as sentiment across German equities brightened, with media reports pointing to hopes of geopolitical de-escalation and retreating oil prices as the day's tailwinds.
The stake disclosure, published the same day, showed BlackRock holding a total position of 4.93% in Hensoldt. Voting rights account for 3.03%, with a further 1.90% held through instruments. The threshold was crossed on Wednesday.
A Backlog That Raises the Stakes
Those market moves, however, sit on top of a far more consequential set of numbers. Hensoldt's first nine months of 2026 delivered order intake of €3.564 billion, a jump of 76.7%. The order book now stands at €10.367 billion — a figure that shifts the debate from demand to delivery. A backlog of that size is a promise on future business, and its economic worth is settled only in the execution.
Revenue for the same period reached €1.863 billion, up 21.3%. The gap between the two growth rates is the heart of the story: orders are compounding far faster than sales. That signals an expanding business base, provided the company converts the additional bookings into billings. Order intake shows how much new business Hensoldt is winning; revenue shows how much of it is already producing income. A convincing trajectory needs both.
Should investors sell immediately? Or is it worth buying Hensoldt?
Profitability Is the Stronger Card
Where the case becomes more persuasive is on earnings. Adjusted EBITDA climbed 33.0% to €281 million, outpacing revenue growth. For investors, that combination of expansion and margin strength carries more weight than order momentum alone — ultimately, what a company earns from its business is what counts.
Guidance, refined upward on Thursday, points to roughly €2.8 billion in revenue for the full 2026 financial year and an adjusted EBITDA margin of around 19.0%. Those targets give a concrete yardstick for the next operational test. The company also expects its order intake-to-revenue ratio to land at the upper end of its prior range of roughly 1.5x to 2.0x for the current year — a plan built on bookings continuing to outstrip sales.
Analysts Split on What the Numbers Are Worth
The quarterly figures drew a divided reception from the research desks. Deutsche Bank Research reaffirmed its buy rating on Friday with a €105 price target; analyst Christophe Menard wrote that Hensoldt had exceeded expectations. JPMorgan, by contrast, kept its "Neutral" stance on Thursday and maintained a €100.0 target.
Hensoldt's progress will therefore be judged chiefly on whether the operating business keeps pace with its enlarged order base. The most convincing evidence would be a continuation of the pattern already on display: rising revenue paired with disproportionately faster growth in adjusted profit. Growth and earnings power advancing together is the standard to watch — and the quality of execution is the test on which investor confidence should rest.
Ad
Hensoldt Stock: New Analysis - 10 November
Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
